Results 21 to 30 of about 129,361 (307)

Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021

open access: yesMMWR. Morbidity and mortality weekly report, 2023
Millions of young children are vaccinated safely in the United States each year against a variety of potentially dangerous infectious diseases (1). The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination against 14 diseases
H. Hill   +4 more
semanticscholar   +1 more source

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020

open access: yesMMWR. Morbidity and mortality weekly report, 2021
The Advisory Committee on Immunization Practices (ACIP) recommends that adolescents aged 11-12 years routinely receive tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) vaccines.
C. Pingali   +8 more
semanticscholar   +1 more source

Racial and Ethnic Differences in COVID-19 Vaccination Coverage Among Children and Adolescents Aged 5–17 Years and Parental Intent to Vaccinate Their Children — National Immunization Survey–Child COVID Module, United States, December 2020–September 2022

open access: yesMMWR. Morbidity and mortality weekly report, 2023
Some racial and ethnic groups are at increased risk for COVID-19 and associated hospitalization and death because of systemic and structural inequities contributing to higher prevalences of high-risk conditions and increased exposure (1).
M. R. Valier   +7 more
semanticscholar   +1 more source

National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021

open access: yesMMWR. Morbidity and mortality weekly report, 2022
CDC’s Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of persons aged 11–12 years with tetanus, diphtheria, and acellular pertussis vaccine (Tdap), human papillomavirus (HPV) vaccine, and quadrivalent meningococcal ...
C. Pingali   +8 more
semanticscholar   +1 more source

Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 — National Immunization Survey-Child, United States, 2020–2022

open access: yesMMWR. Morbidity and mortality weekly report, 2023
National Immunization Survey-Child data collected in 2022 were combined with data from previous years to assemble birth cohorts and assess coverage with routine vaccines by age 24 months by birth cohort.
Holly A. Hill   +4 more
semanticscholar   +1 more source

COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021

open access: yesMMWR. Morbidity and mortality weekly report, 2022
Some racial and ethnic minority groups have experienced disproportionately higher rates of COVID-19-related illness and mortality (1,2). Vaccination is highly effective in preventing severe COVID-19 illness and death (3), and equitable vaccination can ...
J. Kriss   +11 more
semanticscholar   +1 more source

Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019

open access: yesBMC Infectious Diseases, 2022
Introduction The Bacille-Calmette–Guerin (BCG) vaccination remains the primary strategy to prevent severe disseminated TB in young children, particularly in high TB-burden countries such as Ethiopia.
Kendalem Asmare Atalell   +7 more
doaj   +1 more source

Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–January 31, 2022

open access: yesMMWR. Morbidity and mortality weekly report, 2022
Higher COVID-19 incidence and mortality rates in rural than in urban areas are well documented (1). These disparities persisted during the B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant surges during late 2021 and early 2022 (1,2).
Ryan Saelee   +10 more
semanticscholar   +1 more source

Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions

open access: yesHuman Vaccines & Immunotherapeutics, 2023
The Centers for Disease Control recommends pneumococcal vaccination for U.S. adults aged 19–64 years with chronic or immunocompromising conditions, however, vaccination coverage is low and regional variations in coverage are rarely studied.
Junqing Liu   +2 more
doaj   +1 more source

Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults — United States, Fall 2023

open access: yesMMWR. Morbidity and mortality weekly report, 2023
During the 2023-24 respiratory virus season, the Advisory Committee on Immunization Practices recommends influenza and COVID-19 vaccines for all persons aged ≥6 months, and respiratory syncytial virus (RSV) vaccine is recommended for persons aged ≥60 ...
Carla L. Black   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy